October 31. 2018 Consumer Group Responds to Opponents of Sprint/T-Mobile Merger “It is no surprise that opponents of the Sprint […]
Gerard Scimeca – Chairman, CASE October 29, 2018 – https://bit.ly/2PvVw64 In this era of broad political division, one thing that still […]
Gerard Scimeca – Chairman, CASE With the 2018 midterm elections just days away, Florida voters have stark choices up and […]
Almost everyone agrees patients should know what their medicines cost them, and that drug pricing should be made more clear […]
CASE Op-Ed – RealClear Energy: Trump Could Help Consumers Get Relief from Misguided Ethanol Mandates
Gerard Scimeca – Chairman, CASE October 23, 2018 – https://bit.ly/2NZ3Sy4 In his proposal to lift restrictions on year-round sales of gasoline […]
Gerard Scimeca – Chairman, CASE October 15, 2018 – https://bit.ly/2pVyIhO When Henry Ford created an assembly line to mass-produce cars […]
Almost all of Washington seems to have an opinion about the new trade deal the Trump Administration struck with Canada […]
Matthew Kandrach – President, CASE October 12, 2918 – https://bit.ly/2CcBczJ Only one government agency is specifically tasked with consumer protection, in […]
Matthew Kandrach – President, CASE October 9, 2018 – https://bit.ly/2Oihkm5 Recent polling suggests that health care is still very much at the […]
Matthew Kandrach – President, CASE October 8, 2018 – https://bit.ly/2CxCar6 As Toys R Us creditors vie for control of struggling retail […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/